ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Satellos Bioscience (MSCL.TO)
Satellos Bioscience stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Toronto Stock Exchange · Canada
CA$9.67▲ +3.64%
Prices as of Oct 27, 2026 · CAD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Satellos Bioscience in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Satellos Bioscience
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Satellos Bioscience a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CA$8.64 and CA$10.63; in 9 out of 10, between CA$7.19 and CA$12.77. Estimated annual volatility is 52%.
Key numbers
- Market cap
- CA$200M
- Market cap (USD)
- $142M
- Operating margin
- 0.0%
- Net margin
- 0.0%
- Beta
- 1.15
What this means
ATLAS does not publish a fair value for MSCL.TO right now, but it does show its odds of rising: close to a coin flip.
Its beta is 1.15: it moves roughly in line with the market.
About the company
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.
Want to see everything about Satellos Bioscience?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Satellos Bioscience do?
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.
What is the chance MSCL.TO goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, MSCL.TO ends the month between CA$8.64 and CA$10.63.
How big is Satellos Bioscience and what is its P/E ratio?
Satellos Bioscience's market capitalization is CA$200M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is MSCL.TO?
ATLAS estimates annual volatility at 52%. In a typical month, half of the outcomes end between CA$8.64 and CA$10.63.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer